Zurich Cantonal Bank
CSTL icon

Zurich Cantonal Bank’s Castle Biosciences CSTL Stock Holding History

Zurich Cantonal Bank’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Buy
15,579
+551
+4% +$12.3K ﹤0.01% 2094
2026
Q1 		$369K Buy
+15,028
New +$492K ﹤0.01% 1987
2025
Q4 		– Sell
-12,207
Closed -$394K – 2808
2025
Q3 		$278K Buy
12,207
+118
+1% +$2.4K ﹤0.01% 2036
2025
Q2 		$247K Buy
12,089
+8
+0.1% +$148 ﹤0.01% 2035
2025
Q1 		$242K Sell
12,081
-1,561
-11% -$38.6K ﹤0.01% 1995
2024
Q4 		$364K Buy
13,642
+4,166
+44% +$127K ﹤0.01% 1820
2024
Q3 		$270K Sell
9,476
-406
-4% -$10.3K ﹤0.01% 1947
2024
Q2 		$215K Buy
9,882
+952
+11% +$21.2K ﹤0.01% 2004
2024
Q1 		$198K Buy
8,930
+738
+9% +$16.1K ﹤0.01% 2055
2023
Q4 		$177K Buy
8,192
+1,395
+21% +$24.6K ﹤0.01% 2153
2023
Q3 		$115K Buy
6,797
+2,909
+75% +$50.9K ﹤0.01% 2292
2023
Q2 		$53.3K Hold
3,888
– – ﹤0.01% 2601
2023
Q1 		$88.3K Hold
3,888
– – ﹤0.01% 2355
2022
Q4 		$91.5K Sell
3,888
-36
-0.9% -$835 ﹤0.01% 2326
2022
Q3 		$102K Sell
3,924
-57
-1% -$1.6K ﹤0.01% 2206
2022
Q2 		$87K Sell
3,981
-194
-5% -$4.51K ﹤0.01% 2336
2022
Q1 		$187K Sell
4,175
-901
-18% -$37.2K ﹤0.01% 1928
2021
Q4 		$218K Sell
5,076
-75
-1% -$3.92K ﹤0.01% 2010
2021
Q3 		$343K Sell
5,151
-16
-0.3% -$1.13K ﹤0.01% 1545
2021
Q2 		$379K Buy
5,167
+160
+3% +$10.6K ﹤0.01% 1388
2021
Q1 		$343K Buy
5,007
+3,132
+167% +$235K ﹤0.01% 1460
2020
Q4 		$126K Hold
1,875
– – ﹤0.01% 2108
2020
Q3 		$96K Buy
+1,875
New +$83.4K ﹤0.01% 2006

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zurich Cantonal Bank's CSTL Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Castle Biosciences (CSTL) stake by 3.7% in Q2 2026, buying an estimated $12.3K and bringing the position to 15,579 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

Zurich Cantonal Bank first reported a position in CSTL in Q3 2020 and has held it in 23 quarters since. The position peaked at $379K in Q2 2021. 176 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Zurich Cantonal Bank held 15,579 shares of Castle Biosciences worth $372K as of Q2 2026.
  • Zurich Cantonal Bank bought 551 Castle Biosciences shares in Q2 2026, an estimated $12.3K.
  • Castle Biosciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2094 holding.
  • Zurich Cantonal Bank first reported a position in Castle Biosciences in Q3 2020 and has held it in 23 quarters since.
  • Zurich Cantonal Bank's Castle Biosciences position peaked at $379K in Q2 2021.
  • 176 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.